The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-chloro-2-(2,4-dimethoxyphenyl)-3H-imidazo[4,5-g]quinoline ID: ALA3810277
PubChem CID: 127043373
Max Phase: Preclinical
Molecular Formula: C18H14ClN3O2
Molecular Weight: 339.78
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-c2nc3cc4cccnc4c(Cl)c3[nH]2)c(OC)c1
Standard InChI: InChI=1S/C18H14ClN3O2/c1-23-11-5-6-12(14(9-11)24-2)18-21-13-8-10-4-3-7-20-16(10)15(19)17(13)22-18/h3-9H,1-2H3,(H,21,22)
Standard InChI Key: UJUHYXOVRXZGST-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
4.6043 -0.6682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6043 0.8382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3044 1.5915 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3044 -1.4214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9924 -0.6682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9924 0.8382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7168 1.5915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7168 -1.4214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5831 -0.6682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5831 0.8382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0045 1.2999 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8792 0.0850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0045 -1.1298 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.3799 0.0850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2183 -1.1531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.7144 -1.0449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.3687 0.3048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5270 1.5464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0309 1.4382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5648 -2.5042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.2384 -3.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.8655 0.4161 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-9.3874 1.4967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7217 2.7914 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 9 1 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
15 20 1 0
20 21 1 0
17 22 1 0
22 23 1 0
7 24 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 339.78Molecular Weight (Monoisotopic): 339.0775AlogP: 4.45#Rotatable Bonds: 3Polar Surface Area: 60.03Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.04CX Basic pKa: 4.83CX LogP: 3.73CX LogD: 3.73Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.60Np Likeness Score: -0.80
References 1. Carta A, Briguglio I, Piras S, Corona P, Ibba R, Laurini E, Fermeglia M, Pricl S, Desideri N, Atzori EM, La Colla P, Collu G, Delogu I, Loddo R.. (2016) A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems., 117 [PMID:27161176 ] [10.1016/j.ejmech.2016.03.080 ]